Form D · Pharmaceuticals

LAURENT PHARMACEUTICALS INC.

Montreal, A8 · CIK 0001752986

Offering snapshot reported Aug 30, 2021 · SEC filing

Reported sold
$2.54M
Indefinite offering
Investors reported
Not reported
Form D · investor count
Minimum accepted
Not reported
Reported outside-investor minimum
First sale
Not reported
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Aug 30, 2021Amendment$2,543,491No comparisonNot reportedSEC filing
May 29, 2020Amendment$1,887,518$313,134vs Jan 28, 202042SEC filing
Jan 28, 2020Amendment$1,574,384$271,662vs Aug 6, 201939SEC filing
Aug 6, 2019Amendment$1,302,722$124,998vs May 17, 201932SEC filing
May 17, 2019Amendment$1,177,724$0vs May 9, 201930SEC filing
May 9, 2019Amendment$1,177,724$775,118vs Sep 19, 201830SEC filing
Sep 19, 2018Initial$402,606No comparison9SEC filing

Offering details

Securities
Not reported
Exemptions
Not reported
Duration over one year
Not reported
Business combination
Not reported
Sales commissions
Not reported
Finders' fees
Not reported
Form D file number
021-321728

Source: Form D, filed Aug 30, 2021. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Francois Mongrain Director
Radu Cristian Pislariu Director, Executive
Yves Rosconi Director

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:
1010 Sherbrooke St. West Suite 2401
Montreal, A8, H3A 2R7